Archives
-
SNS-032: Reading CDK9 Biology Across Assays
2026-09-17
SNS-032 (BMS-387032) offers a useful pharmacological lens on CDK2, CDK7, and CDK9 signaling. This article connects its oncology assay profile with the distinct experimental logic of a recent SARS-CoV-2 host-factor study while clearly separating established evidence from testable antiviral hypotheses.
-
Cy5 TSA Fluorescence System Kit: Practical Guide
2026-09-16
Learn how to apply HRP-driven Cy5 deposition to amplify weak protein and nucleic-acid signals in IHC, ICC, and FISH. This workflow combines rapid far-red imaging with practical controls for low-abundance intestinal repair markers and tissue-based troubleshooting.
-
Actinomycin D for Reproducible Cell Assays
2026-09-16
This scenario-based guide explains how Actinomycin D (SKU A4448) can support controlled transcriptional inhibition, mRNA stability studies, and cytotoxicity experiments. It covers mechanism, solvent compatibility, protocol design, interpretation limits, and practical supplier-selection criteria for biomedical laboratories.
-
Resolving Pollen Interference in EEM Bioaerosol Detection
2026-09-15
Zhang and colleagues developed a fluorescence-spectrum and machine-learning workflow to reduce pollen interference when classifying hazardous bioaerosol constituents. Fast Fourier transform processing improved random-forest classification to 89.24% across 31 sample types, supporting more reliable discrimination of bacterial and toxin-related signatures in the study dataset.
-
Plant Cell Lysis Buffer: Preserve Signaling
2026-09-15
Plant Cell Lysis Buffer for WB and IP supports non-denaturing protein extraction while protecting phosphorylation states and native interactions. This evidence-centered guide connects buffer chemistry with assay decisions inspired by MAPK10–KRT16 research.
-
Sulfo-Cy3 NHS Ester for Vascular Assays
2026-09-14
Use Sulfo-Cy3 NHS Ester to label proteins, peptides, and nanoparticle surfaces in aqueous workflows that model endothelial uptake and collateral-vessel biology. Its hydrophilic NHS ester chemistry is particularly useful when low-solubility targets, receptor trafficking, or QD-dye conjugates make conventional organic-solvent labeling difficult.
-
IGF2BP3–EPOR mRNA Stability Drives AML Progression
2026-09-14
Fan et al. combine an m6A-related prognostic model with functional experiments to identify IGF2BP3 as a driver of acute myeloid leukemia progression. The study links IGF2BP3 to stabilization of EPOR mRNA and possible activation of JAK/STAT signaling, while also highlighting experimental requirements for validating mRNA stability mechanisms.
-
NF 340: Reliable P2Y11 Assay Design
2026-09-13
This scenario-driven guide explains how NF 340 (SKU B7508) can strengthen mechanistic studies linking P2Y11 signaling with cell viability, proliferation, and cancer-cell invasiveness. It combines literature-grounded interpretation with practical controls for compound preparation, assay compatibility, data comparison, and vendor selection.
-
Cy5 TSA Fluorescence System Kit: Practical Guide
2026-09-12
The Cy5 TSA Fluorescence System Kit strengthens tissue, cell, and hybridization workflows when conventional fluorescence cannot resolve scarce targets. Its HRP-guided, spatially confined Cy5 deposition is especially useful for mapping lipid-metabolism markers such as SCD1 and CD36 in hepatocellular carcinoma research.
-
Optimized hiPSC Platelet Differentiation: Key Findings
2026-09-11
A 2026 study developed an optimized differentiation scheme for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. By combining embryoid-body input optimization, human platelet lysate, cytokine-replacing small molecules, and maturation enhancers, the approach shortened production, increased yield, and reduced reported costs.
-
Prednisone Assay Design: A Transformation-Aware Guide
2026-09-11
Prednisone assay design requires more than measuring viability or cytokines. This guide connects corticosteroid mechanism with transformation-aware experimental controls, showing how to distinguish true immunosuppressive effects from matrix, handling, and sample-preparation artifacts.
-
Psoralen, Isopsoralen, and ERK1/2 Cholestasis
2026-09-10
The reference study shows that psoralen and isopsoralen, estrogen-like constituents of Psoraleae Fructus, produce cholestatic liver injury in zebrafish larvae through estrogen-associated ERK1/2 activation. By combining estrogenicity assays, bile-flow measurements, gene-expression analysis, and pharmacological rescue, the work identifies ERK1/2 as a mechanistically relevant target rather than merely a correlated signaling marker.
-
Berberrubine in Hyperuricemia: Transporters and JAK2/STAT3
2026-09-10
The reference study identifies berberrubine, a major berberine metabolite, as an anti-hyperuricemic agent that acts through coordinated regulation of urate production, renal transport, inflammation, and JAK2/STAT3 signaling. Its mouse data support a multi-target interpretation of hyperuricemia treatment while also highlighting the limits of extrapolating an induced model to other immunometabolic diseases.
-
ARID1A-Dependent Resistance Networks in Melanoma
2026-09-09
The reference study integrates transcriptomic, proteomic, and signaling information to define how ARID1A loss rewires melanoma responses to BRAF/MAPK inhibition. Its network analysis prioritizes PRKD1, JUN, and NCK1 as resistance-associated nodes and provides a practical framework for studying adaptive signaling, immune-evasion features, and therapy durability.
-
Pazopanib (GW-786034) Research Workflows
2026-09-09
Build reproducible angiogenesis, signaling, and tumor-cell assays with Pazopanib (GW-786034), a multi-targeted inhibitor suited to VEGFR, PDGFR, and FGFR biology. An ATRX-stratified glioma workflow shows how to turn pathway inhibition into a more informative precision cancer research experiment.